ZDHHC20 and familial pancreatic carcinoma: To investigate the specific mechanisms by which ZDHHC20 regulates pancreatic cancer progression, we conducted immunoprecipitation–tandem mass spectrometry (IP-MS) to identify potential binding partners of ZDHHC20.